A clinical trial with an expanded cohort would be instrumental to reaffirm the borderline significance observed in key parameters, including the Park score, RANO criteria, and the relationship between preoperative and postoperative tumor volume.
← all excerpts
Repeat Resection for Recurrent Glioblastoma in the WHO 2021 Era: A Longitudinal Matched Case-Control Study.
2
—
—
The sentences
The residual tumor volume and extent of resection did not reach statistical significance following repeat surgery.